#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	1522	CRP	633	633	99.53	CRP.l15.c17.ctg.1	1139	71.6	0	.	p	.	0	K29T	NONSYN	85	87	AAG	289	291	ACG	86;86;87	A;C;G	86;86;87	.	CRP;CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	5836	Escherichia_coli_EF_Tu	1230	1211	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1415	204.5	1	SNP	p	R234F	1	.	.	700	702	TTC	904	906	TTC	266;263;262	T;T,G;C	265;256,1;258	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R234F:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	5836	Escherichia_coli_EF_Tu	1230	1211	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1415	204.5	1	SNP	p	R334C	0	.	.	1000	1002	CGT	1204	1206	CGT	262;264;270	C;G;T	261;264;269	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356:1:1:R334C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	5836	Escherichia_coli_EF_Tu	1230	1211	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1415	204.5	0	HET	.	.	.	C255T	.	255	255	C	459	459	C	213	C,T	95,118	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	5836	Escherichia_coli_EF_Tu	1230	1211	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1415	204.5	0	HET	.	.	.	T90C	.	90	90	T	294	294	T	156	T,C	117,39	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	5836	Escherichia_coli_EF_Tu	1230	1211	99.75	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1415	204.5	0	HET	.	.	.	T180C	.	180	180	T	384	384	T	158	T,C	75,70	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	Escherichia_coli_EF_Tu.3003369.AE014075.3901532_3902762.3356	1	1	167	5836	Escherichia_coli_EF_Tu	1230	72	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.2	241	25.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	2128	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c4.ctg.1	1838	62.1	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1547	1549	AAA	28;27;26	A;A;A	27;27;26	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	2810	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c4.ctg.1	1805	83.4	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1256	1258	GAA	92;92;93	G;A;A	92;92;93	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	688	H_NS	414	414	99.03	H_NS.l6.c30.ctg.1	846	43.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.;H-NS
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	134	95.52	Pasteurella_multocida_16S.l6.c30.ctg.1	135	215.5	0	.	n	.	0	G375A	SNP	375	375	G	73	73	A	209	A	206	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	134	95.52	Pasteurella_multocida_16S.l6.c30.ctg.1	135	215.5	0	.	n	.	0	G383C	SNP	383	383	G	81	81	C	104	C	104	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	134	95.52	Pasteurella_multocida_16S.l6.c30.ctg.1	135	215.5	0	.	n	.	0	G385C	SNP	385	385	G	83	83	C	69	C	67	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	134	95.52	Pasteurella_multocida_16S.l6.c30.ctg.1	135	215.5	0	.	n	.	0	C388G	SNP	388	388	C	86	86	G	41	G	41	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	134	95.52	Pasteurella_multocida_16S.l6.c30.ctg.1	135	215.5	0	.	n	.	0	C394T	SNP	394	394	C	92	92	T	15	T	15	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	134	95.52	Pasteurella_multocida_16S.l6.c30.ctg.1	135	215.5	0	.	n	.	0	A411T	SNP	411	411	A	109	109	T	7	T	7	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	T1041G	SNP	1041	1041	T	16	16	G	361	G	263	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	A1042T	SNP	1042	1042	A	17	17	T	373	T	272	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	A1136G	SNP	1136	1136	A	111	111	G	400	G	394	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	T1138C	SNP	1138	1138	T	113	113	C	374	C	374	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	T1142C	SNP	1142	1142	T	117	117	C	345	C	343	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	C1170T	SNP	1170	1170	C	145	145	T	383	T	380	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	T1220C	SNP	1220	1220	T	195	195	C	456	C,A	454,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	T1245C	SNP	1245	1245	T	220	220	C	407	C	406	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	G1253A	SNP	1253	1253	G	228	228	A	415	A	415	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	G1256A	SNP	1256	1256	G	231	231	A	407	A	407	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	C1258A	SNP	1258	1258	C	233	233	A	402	A	402	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	G1266T	SNP	1266	1266	G	241	241	T	364	T	360	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	T1267C	SNP	1267	1267	T	242	242	C	356	C	356	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	T1275C	SNP	1275	1275	T	250	250	C	299	C	299	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	G1276A	SNP	1276	1276	G	251	251	A	284	A	283	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	A1281G	SNP	1281	1281	A	256	256	G	252	G	252	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	T1283C	SNP	1283	1283	T	258	258	C	248	C,T	244,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	G1288T	SNP	1288	1288	G	263	263	T	257	T	257	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	A1296G	SNP	1296	1296	A	271	271	G	301	G	301	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	T1299G	SNP	1299	1299	T	274	274	G	312	G	312	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	A1300T	SNP	1300	1300	A	275	275	T	316	T	316	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	C1356T	SNP	1356	1356	C	331	331	T	474	T	473	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	A1358G	SNP	1358	1358	A	333	333	G	456	G	452	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	T1368C	SNP	1368	1368	T	343	343	C	377	C	377	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	G1370A	SNP	1370	1370	G	345	345	A	343	A	341	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	C1406.	DEL	1406	1406	C	380	380	C	135	C	135	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	.1409C	INS	1409	1409	T	384	384	C	122	C	121	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	C1431A	SNP	1431	1431	C	406	406	A	10	A	10	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	C1432A	SNP	1432	1432	C	407	407	A	11	A	11	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	A1441G	SNP	1441	1441	A	416	416	G	14	G	14	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	T1464C	SNP	1464	1464	T	439	439	C	77	C	76	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	G1473T	SNP	1473	1473	G	448	448	T	185	T	185	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	A1475G	SNP	1475	1475	A	450	450	G	212	G	211	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	.	n	.	0	A1548T	SNP	1548	1548	A	523	523	T	155	T	155	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	1	SNP	n	C1194G	0	.	.	1194	1194	C	169	169	C	444	C	441	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	640	7812	Pasteurella_multocida_16S	1551	526	91.84	Pasteurella_multocida_16S.l6.c30.ctg.3	563	358.8	0	HET	.	.	.	T1040C,G	.	1040	1040	T	15	15	T	312	T,C,G	112,101,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	2348	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1592	79.1	0	.	p	.	0	H2R	NONSYN	4	6	CAT	262	264	CGT	82;87;87	C;G;T	82;82;86	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	2348	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1592	79.1	0	.	p	.	0	V30I	NONSYN	88	90	GTC	346	348	ATC	90;88;87	A,G;T;C	88,2;88;87	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	2348	PmrB_1	1092	1092	99.08	PmrB_1.l15.c30.ctg.1	1592	79.1	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1105	1107	GGC	92;94;94	G;G;C	91;93;94	.	PmrB;Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+)
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	3408	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2044	89.4	0	.	p	.	0	R8S	NONSYN	22	24	AGA	233	235	AGC	35;37;37	A;G;C	35;37;37	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	3408	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2044	89.4	0	.	p	.	0	I142L	NONSYN	424	426	ATA	635	637	CTA	91;90;90	C;T,A;A	89;87,2;89	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	3408	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2044	89.4	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1154	1156	CAA	110;111;112	C;A;A	110;110;112	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	3408	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2044	89.4	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1253	1255	GGT	139;136;136	G;G;T	139;136;136	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	3408	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2044	89.4	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1823	1825	GTT	54;54;53	G;T;T	54;53;51	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1514	PmrE	1167	1167	96.83	PmrE.l15.c17.ctg.1	1578	51.7	0	.	p	.	0	A125E	NONSYN	373	375	GCA	569	571	GAA	48;47;48	G;A;A	48;47;48	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1514	PmrE	1167	1167	96.83	PmrE.l15.c17.ctg.1	1578	51.7	0	.	p	.	0	M185T	NONSYN	553	555	ATG	749	751	ACC	18;18;18	A;C;C	18;18;18	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1514	PmrE	1167	1167	96.83	PmrE.l15.c17.ctg.1	1578	51.7	0	.	p	.	0	S225T	NONSYN	673	675	TCC	869	871	ACT	28;26;25	A;C;T	28;24;25	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	1514	PmrE	1167	1167	96.83	PmrE.l15.c17.ctg.1	1578	51.7	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1259	1261	ATC	40;39;41	A;T;C	40;39;41	.	PmrE;PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	1710	PmrF	969	969	99.38	PmrF.l6.c30.ctg.1	1358	67.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	513	122	TEM_1+	858	97	98.97	TEM_1+.l15.c4.ctg.1	150	4.3	0	.	p	.	0	F19L	NONSYN	55	57	TTT	108	110	CTT	8;8;8	C;T;T	8;8;8	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	513	122	TEM_1+	858	396	99.24	TEM_1+.l15.c4.ctg.2	398	6.2	0	.	p	.	0	H162R	NONSYN	484	486	CAT	106	108	CGT	6;6;6	C;G;T	6;6;6	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	513	122	TEM_1+	858	138	98.55	TEM_1+.l15.c4.ctg.3	138	8.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
TEM_187.3001047.HM246246.211_1069.1956	TEM_187.3001047.HM246246.211_1069.1956	1	0	513	122	TEM_1+	858	126	100.0	TEM_1+.l15.c4.ctg.5	130	9.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TEM-187;TEM-187 is an extended-spectrum beta-lactamase found in P. mirabilis
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	5836	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3501	89.7	0	.	p	.	0	T85I	NONSYN	253	255	ACC	450	452	ATC	82;82;86	A;T;C	82;82;86	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	5836	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3501	89.7	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2163	2165	AAG	60;60;60	A;A;G	60;59;59	.	AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.;acrD
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	2326	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1563	79.7	0	.	p	.	0	A22V	NONSYN	64	66	GCC	263	265	GTC	31;34;33	G;T;C	31;34;33	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	2326	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1563	79.7	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1004	1006	TGC	104;102;106	T;G;C	103;100;104	.	AcrE is a membrane fusion protein, similar to AcrA.;acrE
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	6040	acrF	3105	3105	98.52	acrF.l15.c4.ctg.1	3339	95.6	0	.	p	.	0	S46trunc	TRUNC	136	136	T	164	164	T	67	T	66	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	6040	acrF	3105	3105	98.52	acrF.l15.c4.ctg.1	3339	95.6	0	.	p	.	0	G148D	NONSYN	442	444	GGC	470	472	GAC	88;88;88	G;A;C	87;87;87	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	6040	acrF	3105	3105	98.52	acrF.l15.c4.ctg.1	3339	95.6	0	.	p	.	0	F240L	NONSYN	718	720	TTT	746	748	TTA	39;40;39	T;T;A	39;40;39	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	6040	acrF	3105	3105	98.52	acrF.l15.c4.ctg.1	3339	95.6	0	.	p	.	0	D301N	NONSYN	901	903	GAT	929	931	AAT	68;69;66	A,G;A;T	67,1;69;66	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	531	6040	acrF	3105	3105	98.52	acrF.l15.c4.ctg.1	3339	95.6	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	1716	1716	T	126	T	126	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	1408	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1085	69.7	1	SNP	p	R45C	0	.	.	133	135	CGC	344	346	CGC	100;100;103	C;G;C	100;100;103	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	1058	acrS	663	663	98.64	acrS.l15.c4.ctg.1	1083	52.6	0	.	p	.	0	L34F	NONSYN	100	102	CTC	359	361	TTC	51;50;49	T;T;C	51;50;49	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	1058	acrS	663	663	98.64	acrS.l15.c4.ctg.1	1083	52.6	0	.	p	.	0	E122G	NONSYN	364	366	GAG	623	625	GGG	95;92;93	G;G;G	93;90;92	.	AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.;acrS
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	1496	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1182	67.7	0	.	p	.	0	V136L	NONSYN	406	408	GTT	609	611	CTT	109;107;107	C;T;T	109;107;107	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	5956	alaS	2631	2631	98.9	alaS.l6.c4.ctg.1	3084	103.9	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2064	2066	GCA	152;158;163	G,C;C;A	151,1;158;163	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	5956	alaS	2631	2631	98.9	alaS.l6.c4.ctg.1	3084	103.9	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2325	2327	ACC	107;111;115	A;C;C	105;109;114	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	5956	alaS	2631	2631	98.9	alaS.l6.c4.ctg.1	3084	103.9	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2634	2636	GCC	96;92;93	G;C;C	96;88;91	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2686	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2276	62.8	0	.	p	.	0	G37A	NONSYN	109	111	GGT	187	189	GCT	16;18;18	G;C;T	16;18;18	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2686	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2276	62.8	0	.	p	.	0	D77E	NONSYN	229	231	GAT	307	309	GAG	16;16;15	G;A;G	16;16;15	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2686	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2276	62.8	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	343	345	TGC	19;18;20	T;G;C	18;18;19	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2686	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2276	62.8	0	.	p	.	0	I150V	NONSYN	448	450	ATT	526	528	GTT	38;41;42	G;T;T	37;41;42	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2686	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2276	62.8	0	.	p	.	0	R200H	NONSYN	598	600	CGC	676	678	CAC	44;41;41	C;A;C	44;40;41	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2686	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2276	62.8	0	.	p	.	0	T295M	NONSYN	883	885	ACG	961	963	ATG	83;85;86	A;T;G	81;83;83	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	2686	arnA_1	1983	1983	98.29	arnA_1.l15.c4.ctg.1	2276	62.8	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	1957	1959	CGC	59;57;57	C;G;C	58;56;57	.	arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.;arnA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	1322	bacA	822	822	98.54	bacA.l15.c17.ctg.1	1287	55.1	0	.	p	.	0	S221T	NONSYN	661	663	AGC	918	920	ACC	43;43;42	A;C;C	43;43;41	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	1322	bacA	822	822	98.54	bacA.l15.c17.ctg.1	1287	55.1	0	.	p	.	0	P225S	NONSYN	673	675	CCG	930	932	TCG	52;52;50	T;C;G	52;52;50	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	1400	baeR	723	723	97.79	baeR.l15.c30.ctg.1	1119	67.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	2446	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1798	73.1	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1302	1304	AAA	41;42;42	A;A;A	36;41;41	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	2446	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1798	73.1	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1314	1316	GAG	44;42;42	G,C;A;G	35,1;37;39	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	2446	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1798	73.1	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1320	1322	CAC	48;52;49	C;A;C	46;49;48	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	2446	baeS	1404	1404	98.86	baeS.l15.c17.ctg.1	1798	73.1	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1374	1376	GAG	78;74;73	G;A;G	78;74;73	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	2794	cpxA	1374	1374	98.91	cpxA.l15.c30.ctg.1	1836	81.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.;cpxA
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	1634	cpxR	699	699	99.43	cpxR.l15.c17.ctg.1	1125	78.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	1870	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1410	71.3	0	.	p	.	0	A146T	NONSYN	436	438	GCT	681	683	ACT	97;92;91	A,G;C;T	93,4;92;91	.	aminocoumarin resistant cysB;Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	2258	emrA	1173	1173	98.29	emrA.l6.c30.ctg.1	1638	73.8	0	.	p	.	0	I219V	NONSYN	655	657	ATC	913	915	GTC	117;111;112	G;T;C	115;107;107	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	3386	emrB	1539	1539	99.74	emrB.l15.c4.ctg.1	1910	95.0	0	.	p	.	0	E197K	NONSYN	589	591	GAA	776	778	AAA	95;96;96	A;A;A	94;95;95	.	emrB;emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	2070	emrD	1191	1191	98.4	emrD.l15.c30.ctg.1	1561	70.8	0	.	p	.	0	G209S	NONSYN	625	627	GGC	807	809	AGC	60;60;59	A;G;C	60;60;59	.	emrD;EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	16	92	emrE_1	333	136	92.65	emrE_1.l15.c30.ctg.1	136	11.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1692	emrK	1056	1056	98.2	emrK.l6.c30.ctg.1	1508	60.4	0	.	p	.	0	K176R	NONSYN	526	528	AAG	732	734	AGG	44;44;44	A;G;G	44;43;44	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	1692	emrK	1056	1056	98.2	emrK.l6.c30.ctg.1	1508	60.4	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1122	1124	GAC	38;39;38	G,A;A;C	37,1;39;38	.	emrK;emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	1288	emrR	531	531	100.0	emrR.l15.c4.ctg.1	1014	68.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	2688	emrY	1539	1539	99.81	emrY.l15.c17.ctg.1	1984	72.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.;emrY
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	1088	evgA	615	615	99.19	evgA.l15.c17.ctg.1	1039	56.2	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	386	388	CTG	63;63;62	C;T;G	63;63;61	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	T38I	NONSYN	112	114	ACA	301	303	ATA	27;29;25	A;T;A	27;29;24	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	L42V	NONSYN	124	126	CTA	313	315	GTA	26;27;28	G;T;A	26;27;28	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	A93T	NONSYN	277	279	GCG	466	468	ACG	52;53;54	A;C;G	52;53;54	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	A114E	NONSYN	340	342	GCA	529	531	GAA	72;76;77	G;A;A	71;76;77	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	T127A	NONSYN	379	381	ACT	568	570	GCT	93;90;85	G,T;C;T	92,1;90;85	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	N133D	NONSYN	397	399	AAT	586	588	GAT	66;63;63	G;A;T	66;62;63	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	P162S	NONSYN	484	486	CCA	673	675	TCA	64;65;66	T;C;A	63;65;66	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	802	804	CAG	32;28;29	C;A;G	31;28;29	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	I251V	NONSYN	751	753	ATT	940	942	GTT	35;35;36	G;T;T	35;35;36	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1096	1098	GAT	23;22;22	G;A;T	23;22;22	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1264	1266	AAT	22;21;20	A;A;T	22;21;19	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1285	1287	TTA	6;6;6	T;T;A	6;6;6	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1486	1488	AAA	51;50;50	A;A;A	51;50;49	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2221	2223	CAT	62;61;60	C;A;T	62;61;60	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2275	2277	CAT	46;46;45	C;A;T	46;46;45	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2293	2295	AGA	30;29;28	A;G;A	30;29;28	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2308	2310	AAT	39;36;34	A;A;T	39;36;34	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2455	2457	TCC	28;26;28	T;C;C	28;26;28	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2620	2622	ATT	54;52;51	A;T;T	54;52;51	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2641	2643	GAT	54;57;59	G;A;T	54;57;59	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2755	2757	GTT	81;78;78	G;T;T	81;77;78	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	5090	evgS	3594	3594	97.55	evgS.l15.c17.ctg.1	4024	68.1	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3040	3042	CAC	73;75;76	C;A;C	72;75;75	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1690	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1202	75.5	1	SNP	p	P64A	0	.	.	190	192	CCA	355	357	CCA	125;125;126	C;C;A	125;124;125	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1690	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1202	75.5	1	SNP	p	P64R	0	.	.	190	192	CCA	355	357	CCA	125;125;126	C;C;A	125;124;125	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1690	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1202	75.5	1	SNP	p	P64H	0	.	.	190	192	CCA	355	357	CCA	125;125;126	C;C;A	125;124;125	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1690	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1202	75.5	1	SNP	p	P64L	0	.	.	190	192	CCA	355	357	CCA	125;125;126	C;C;A	125;124;125	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	1690	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1202	75.5	1	SNP	p	P64S	0	.	.	190	192	CCA	355	357	CCA	125;125;126	C;C;A	125;124;125	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	1030	gadE	528	528	100.0	gadE.l15.c4.ctg.1	960	57.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.;gadE
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	352	gadW	729	165	96.97	gadW.l15.c4.ctg.1	166	46.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	352	gadW	729	317	93.06	gadW.l15.c4.ctg.2	317	19.6	0	.	p	.	0	E54D	NONSYN	160	162	GAA	18	20	GAT	4;5;6	G;A;T	4;5;6	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	352	gadW	729	317	93.06	gadW.l15.c4.ctg.2	317	19.6	0	.	p	.	0	I88M	NONSYN	262	264	ATA	120	122	ATG	11;11;11	A;T;G	11;11;11	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	352	gadW	729	317	93.06	gadW.l15.c4.ctg.2	317	19.6	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	123	125	CCG	10;10;11	C;C;G	10;10;11	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	352	gadW	729	317	93.06	gadW.l15.c4.ctg.2	317	19.6	0	.	p	.	0	D100E	NONSYN	298	300	GAC	156	158	GAA	3;3;3	G;A;A	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	352	gadW	729	317	93.06	gadW.l15.c4.ctg.2	317	19.6	0	.	p	.	0	P101S	NONSYN	301	303	CCC	159	161	TCC	3;3;3	T;C;C	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	352	gadW	729	317	93.06	gadW.l15.c4.ctg.2	317	19.6	0	.	p	.	0	R102G	NONSYN	304	306	CGG	162	164	GGG	2;2;2	G;G;G	2;2;2	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	512	352	gadW	729	317	93.06	gadW.l15.c4.ctg.2	317	19.6	0	.	p	.	0	K110N	NONSYN	328	330	AAA	186	188	AAT	8;9;8	A;A;T	8;9;8	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1220	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1180	55.5	0	.	p	.	0	F53L	NONSYN	157	159	TTC	309	311	TTA	57;59;61	T;T;A	57;59;61	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1220	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1180	55.5	0	.	p	.	0	V79I	NONSYN	235	237	GTT	387	389	ATT	54;54;52	A;T;T	53;54;52	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1220	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1180	55.5	0	.	p	.	0	R246G	NONSYN	736	738	AGA	888	890	GGA	53;53;51	G;G;A	53;53;50	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1220	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1180	55.5	0	.	p	.	0	S248P	NONSYN	742	744	TCG	894	896	CCG	47;45;45	C;C;G	47;45;45	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	5792	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3106	100.4	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2227	2229	GAA	113;113;114	G;A;A	113;113;113	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	5792	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3106	100.4	1	SNP	p	S83I	0	.	.	247	249	TCG	442	444	TCG	124;124;125	T;C;G	124;124;125	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	5792	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3106	100.4	1	SNP	p	S83L	0	.	.	247	249	TCG	442	444	TCG	124;124;125	T;C;G	124;124;125	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	5792	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3106	100.4	1	SNP	p	S83W	0	.	.	247	249	TCG	442	444	TCG	124;124;125	T;C;G	124;124;125	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	5792	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3106	100.4	1	SNP	p	D87G	0	.	.	259	261	GAC	454	456	GAC	109;109;104	G;A,G;C	105;106,1;102	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	5792	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3106	100.4	1	SNP	p	D87Y	0	.	.	259	261	GAC	454	456	GAC	109;109;104	G;A,G;C	105;106,1;102	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	5792	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3106	100.4	1	SNP	p	D87V	0	.	.	259	261	GAC	454	456	GAC	109;109;104	G;A,G;C	105;106,1;102	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	5792	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3106	100.4	1	SNP	p	D87H	0	.	.	259	261	GAC	454	456	GAC	109;109;104	G;A,G;C	105;106,1;102	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	5792	gyrA_7	2628	2628	98.71	gyrA_7.l15.c4.ctg.1	3106	100.4	1	SNP	p	D87N	0	.	.	259	261	GAC	454	456	GAC	109;109;104	G;A,G;C	105;106,1;102	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	4384	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2922	80.7	1	SNP	p	R136I	0	.	.	406	408	CGC	654	656	CGC	71;74;73	C;G;C	70;73;72	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	4384	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2922	80.7	1	SNP	p	R136L	0	.	.	406	408	CGC	654	656	CGC	71;74;73	C;G;C	70;73;72	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	4384	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2922	80.7	1	SNP	p	R136G	0	.	.	406	408	CGC	654	656	CGC	71;74;73	C;G;C	70;73;72	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	4384	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2922	80.7	1	SNP	p	R136H	0	.	.	406	408	CGC	654	656	CGC	71;74;73	C;G;C	70;73;72	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	4384	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2922	80.7	1	SNP	p	R136E	0	.	.	406	408	CGC	654	656	CGC	71;74;73	C;G;C	70;73;72	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	4384	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2922	80.7	1	SNP	p	R136S	0	.	.	406	408	CGC	654	656	CGC	71;74;73	C;G;C	70;73;72	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	4384	gyrB_1	2415	2415	99.05	gyrB_1.l15.c30.ctg.1	2922	80.7	1	SNP	p	R136C	0	.	.	406	408	CGC	654	656	CGC	71;74;73	C;G;C	70;73;72	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	1036	kdpE	678	678	98.23	kdpE.l6.c30.ctg.1	1107	50.3	0	.	p	.	0	A72P	NONSYN	214	216	GCG	421	423	CCG	61;60;54	C;C;G	61;60;54	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	1036	kdpE	678	678	98.23	kdpE.l6.c30.ctg.1	1107	50.3	0	.	p	.	0	T123A	NONSYN	367	369	ACC	574	576	GCC	55;58;56	G;C;C	55;58;56	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	2086	leuO	945	945	99.26	leuO.l15.c4.ctg.1	1346	83.1	0	.	p	.	0	P9S	NONSYN	25	27	CCA	222	224	TCA	61;61;62	T;C,T;A	61;59,1;62	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	884	marA	384	384	99.74	marA.l15.c4.ctg.1	775	61.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	marA;In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	544	marR	435	435	97.7	marR.l15.c30.ctg.1	820	35.7	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	537	539	AGC	52;51;49	A;G;C	51;49;49	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	544	marR	435	435	97.7	marR.l15.c30.ctg.1	820	35.7	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	639	641	CAT	14;11;11	C;A;T	12;9;11	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	544	marR	435	435	97.7	marR.l15.c30.ctg.1	820	35.7	1	SNP	p	V45E	0	.	.	133	135	GTG	363	365	GTG	89;87;86	G;T;G	87;85;86	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	544	marR	435	435	97.7	marR.l15.c30.ctg.1	820	35.7	1	SNP	p	I49S	0	.	.	145	147	ATC	375	377	ATC	90;89;88	A;T;C	90;88;87	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	544	marR	435	435	97.7	marR.l15.c30.ctg.1	820	35.7	1	SNP	p	A70T	0	.	.	208	210	GCA	438	440	GCA	56;57;55	G;C;A	56;57;55	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	544	marR	435	435	97.7	marR.l15.c30.ctg.1	820	35.7	1	SNP	p	R73S	0	.	.	217	219	CGT	447	449	CGT	54;52;51	C;G;T	54;52;50	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	544	marR	435	435	97.7	marR.l15.c30.ctg.1	820	35.7	1	SNP	p	R73C	0	.	.	217	219	CGT	447	449	CGT	54;52;51	C;G;T	54;52;50	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	544	marR	435	435	97.7	marR.l15.c30.ctg.1	820	35.7	1	SNP	p	R77C	0	.	.	229	231	CGC	459	461	CGC	49;49;49	C;G;C	49;49;49	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	544	marR	435	435	97.7	marR.l15.c30.ctg.1	820	35.7	1	SNP	p	R77L	0	.	.	229	231	CGC	459	461	CGC	49;49;49	C;G;C	49;49;49	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	544	marR	435	435	97.7	marR.l15.c30.ctg.1	820	35.7	1	SNP	p	L78M	0	.	.	232	234	CTG	462	464	CTG	49;48;44	C;T;G	49;48;44	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	544	marR	435	435	97.7	marR.l15.c30.ctg.1	820	35.7	1	SNP	p	R94S	0	.	.	280	282	CGC	510	512	CGC	48;47;46	C;G;C	48;47;46	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	544	marR	435	435	97.7	marR.l15.c30.ctg.1	820	35.7	1	SNP	p	R94H	0	.	.	280	282	CGC	510	512	CGC	48;47;46	C;G;C	48;47;46	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	544	marR	435	435	97.7	marR.l15.c30.ctg.1	820	35.7	1	SNP	p	V96E	0	.	.	286	288	GTA	516	518	GTA	46;48;49	G;T;A	45;46;49	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1704	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1428	62.3	0	.	p	.	0	S7F	NONSYN	19	21	TCC	45	47	TTC	13;13;13	T;T;C	13;13;13	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1704	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1428	62.3	0	.	p	.	0	R36I	NONSYN	106	108	AGG	132	134	ATC	30;30;30	A;T;C	30;29;29	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1704	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1428	62.3	0	.	p	.	0	E42A	NONSYN	124	126	GAA	150	152	GCC	8;8;9	G;C;C	8;8;9	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1704	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1428	62.3	0	.	p	.	0	N43V	NONSYN	127	129	AAT	153	155	GTG	9;9;10	G;T;G	9;9;10	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1704	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1428	62.3	0	.	p	.	0	E52D	NONSYN	154	156	GAG	180	182	GAT	15;17;17	G;A;T	15;17;17	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1704	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1428	62.3	0	.	p	.	0	N59T	NONSYN	175	177	AAC	201	203	ACC	20;21;21	A;C;C	20;21;21	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1704	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1428	62.3	0	.	p	.	0	I68L	NONSYN	202	204	ATA	228	230	TTA	33;35;34	T;T;A	33;35;34	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1704	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1428	62.3	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	369	371	CAG	85;86;82	C;A;G	85;86;82	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1704	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1428	62.3	0	.	p	.	0	D128A	NONSYN	382	384	GAC	408	410	GCC	68;69;69	G;C;C	68;69;69	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1704	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1428	62.3	0	.	p	.	0	S163A	NONSYN	487	489	TCG	513	515	GCG	76;78;79	G;C;G	75;78;79	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1704	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1428	62.3	0	.	p	.	0	L231V	NONSYN	691	693	CTT	717	719	GTT	48;48;48	G,T;T;T	35,1;45;41	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	1704	mdfA	1233	1233	97.0	mdfA.l15.c17.ctg.1	1428	62.3	0	.	p	.	0	R285fs	FSHIFT	853	853	C	879	879	C	56	C	55	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1732	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1725	54.0	0	.	p	.	0	V12trunc	TRUNC	34	34	G	227	227	G	53	G	53	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1732	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1725	54.0	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	284	286	CAG	37;36;34	C;A;G	37;36;34	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1732	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1725	54.0	0	.	p	.	0	T83I	NONSYN	247	249	ACC	434	436	ATC	48;48;42	A;T;C	48;48;42	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1732	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1725	54.0	0	.	p	.	0	I99M	NONSYN	295	297	ATA	482	484	ATG	30;30;31	A;T;G	30;30;31	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	1732	mdtA	1248	1248	97.44	mdtA.l15.c4.ctg.1	1725	54.0	0	.	p	.	0	A130T	NONSYN	388	390	GCC	575	577	ACC	61;61;62	A;C;C	59;61;62	.	mdtA;MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	6410	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3543	97.2	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2020	2022	ACC	128;127;128	A;C;C	128;127;128	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	6410	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3543	97.2	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2413	2415	CAA	74;74;72	C;A;A	70;71;67	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	6410	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3543	97.2	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2581	2583	ATT	53;56;55	A;T;T	53;55;53	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	6410	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3543	97.2	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2665	2667	GTT	102;102;103	G;T;T	102;102;103	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	6410	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3543	97.2	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2773	2775	GAG	84;85;82	G;A;G	83;83;82	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	6410	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3543	97.2	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3001	3003	ATG	70;71;72	A;T;G	70;71;72	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	6410	mdtB	3123	3123	98.98	mdtB.l15.c30.ctg.1	3543	97.2	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3136	3138	GAT	90;89;90	G;A;T	89;86;88	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	5688	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3293	91.2	0	.	p	.	0	I46M	NONSYN	136	138	ATC	304	306	ATG	37;37;38	A;T;G	36;35;38	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	5688	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3293	91.2	0	.	p	.	0	V208I	NONSYN	622	624	GTC	790	792	ATC	109;113;116	A;T;C	109;112;116	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	5688	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3293	91.2	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3106	3108	CAC	19;19;18	C;A;C	18;17;18	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	5688	mdtC	3078	3078	98.64	mdtC.l15.c30.ctg.1	3293	91.2	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3109	3111	CTC	17;16;15	C;T;C	17;16;14	.	MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.;mdtC
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	2672	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1825	78.6	0	.	p	.	0	D3E	NONSYN	7	9	GAT	169	171	GAA	63;64;62	G;A;A	62;64;62	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	2672	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1825	78.6	0	.	p	.	0	T226A	NONSYN	676	678	ACG	838	840	GCG	98;99;99	G;C;G	98;98;99	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	2672	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1825	78.6	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1180	1182	ATC	77;76;76	A;T;C,T	75;75;74,1	.	mdtD;Efflux pump mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	2672	mdtD	1416	1416	98.38	mdtD.l15.c30.ctg.1	1825	78.6	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1483	1485	TTT	115;115;113	T;T;T,A	115;115;112,1	.	mdtD;Efflux pump mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	2634	mdtE	1158	1158	99.31	mdtE.l15.c4.ctg.1	1632	86.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.;mdtE
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	6272	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3571	94.4	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1077	1079	ACC	95;95;92	A;C,A;C	94;84,1;90	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	6272	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3571	94.4	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2319	2321	GAC	111;106;102	G;A;C	108;105;101	.	mdtF;MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	2428	mdtG	1227	1047	99.43	mdtG.l15.c4.ctg.1	1498	73.1	0	.	p	.	0	V200I	NONSYN	598	600	GTC	642	644	ATC	85;85;83	A;T;C	85;85;83	.	Efflux protien mdtG.;mdtG
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	2428	mdtG	1227	182	99.45	mdtG.l15.c4.ctg.2	596	34.4	0	.	p	.	0	E5G	NONSYN	13	15	GAA	237	239	GGA	23;24;24	G;G;A	23;24;24	.	Efflux protien mdtG.;mdtG
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	2076	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1533	72.8	0	.	p	.	0	G134C	NONSYN	400	402	GGT	584	586	TGT	109;111;112	T;G;T	109;111;112	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	2076	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1533	72.8	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1154	1156	TTG	82;82;82	T;T;G	82;82;81	.	mdtH;Multidrug resistance protein MdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	2076	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1533	72.8	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1364	1366	ACG	33;34;34	A;C;G	33;34;34	.	mdtH;Multidrug resistance protein MdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	2308	mdtL	1176	1176	98.38	mdtL.l6.c30.ctg.1	1695	73.2	0	.	p	.	0	A185S	NONSYN	553	555	GCC	774	776	TCC	62;60;61	T;C;C	59;59;61	.	mdtL;Multidrug resistance protein MdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	1570	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1456	57.8	0	.	p	.	0	V119I	NONSYN	355	357	GTT	554	556	ATT	44;41;41	A;T;T	42;41;40	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	3788	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2395	84.9	0	.	p	.	0	V11M	NONSYN	31	33	GTG	175	177	ATG	49;51;54	A;T;G,A	48;50;52,1	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	3788	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2395	84.9	0	.	p	.	0	T33I	NONSYN	97	99	ACC	241	243	ATC	58;59;58	A;T;C	58;58;58	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	3788	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2395	84.9	0	.	p	.	0	C116R	NONSYN	346	348	TGC	490	492	CGC	129;126;124	C;G;C	128;126;124	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	3788	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2395	84.9	0	.	p	.	0	N238S	NONSYN	712	714	AAC	856	858	AGC	87;87;88	A;G;C	87;86;88	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	3788	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2395	84.9	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1057	1059	GTG	75;73;73	G;T;G	75;71;73	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	3788	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2395	84.9	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1120	1122	AAC	32;31;29	A;A;C	32;30;29	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	3788	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2395	84.9	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1165	1167	GTC	78;78;79	G;T;C	78;78;79	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	3788	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2395	84.9	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1195	1197	ATA	121;121;119	A;T;A	119;120;117	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	3788	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2395	84.9	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1303	1305	TCT	65;65;66	T;C;T	65;65;66	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	3788	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2395	84.9	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1690	1692	GCG	105;110;110	G;C;G	105;109;110	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	3788	mdtO	2052	2052	98.1	mdtO.l15.c4.ctg.1	2395	84.9	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	1903	1905	ATC	91;89;88	A,T;T;C	89,1;89;88	.	mdtO;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	2236	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1926	62.2	0	.	p	.	0	S129A	NONSYN	385	387	TCA	662	664	GCG	82;79;78	G,T;C;G	81,1;78;76	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	2236	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1926	62.2	0	.	p	.	0	A187T	NONSYN	559	561	GCC	836	838	ACC	50;52;53	A;C;C	50;52;53	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	2236	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1926	62.2	0	.	p	.	0	H211R	NONSYN	631	633	CAC	908	910	CGC	81;80;80	C;G;C	81;80;79	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	2236	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1926	62.2	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1025	1027	GCT	74;74;71	G;C;T	73;73;71	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	2236	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1926	62.2	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1109	1111	AAA	39;36;36	A;A;A	39;36;36	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	2236	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1926	62.2	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1127	1129	CGA	50;54;55	C;G;A	50;54;55	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	2236	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1926	62.2	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1292	1294	GCC	59;58;60	G;C;C	59;58;60	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	2236	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1926	62.2	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1304	1306	GAT	68;69;72	G;A;T	68;69;71	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	2236	mdtP	1467	1467	97.96	mdtP.l15.c30.ctg.1	1926	62.2	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1721	1723	GCT	23;22;22	G;C;T	23;22;22	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	7010	mfd	3447	3447	99.16	mfd.l15.c17.ctg.1	3845	97.9	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1510	1512	AAG	77;76;76	A,G;A;G	75,1;75;76	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	7010	mfd	3447	3447	99.16	mfd.l15.c17.ctg.1	3845	97.9	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2587	2589	CTG	99;99;94	C;T;G	97;98;94	.	mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.;mfd
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	520	mgrB	144	144	100.0	mgrB.l6.c4.ctg.1	633	44.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	3990	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2101	102.1	0	.	p	.	0	S278N	NONSYN	832	834	AGC	988	990	AAC	94;97;98	A;A;C	94;97;98	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	3990	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2101	102.1	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1534	1536	ATA	128;128;132	A;T;A	128;128;132	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	2770	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1708	87.3	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1365	1367	GAT	131;134;134	G;A;T	131;134;134	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	2770	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1708	87.3	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1368	1370	CTG	132;133;131	C;T;G	132;132;130	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1138	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1146	53.3	0	.	p	.	0	R27C	NONSYN	79	81	CGT	282	284	TGT	66;62;65	T;G;T	66;62;65	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1138	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1146	53.3	0	.	p	.	0	I117T	NONSYN	349	351	ATC	552	554	ACC	81;80;79	A;C;C	80;80;79	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1138	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1146	53.3	0	.	p	.	0	G187D	NONSYN	559	561	GGC	762	764	GAC	63;63;63	G;A;C	63;63;63	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1138	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1146	53.3	1	SNP	p	R15C	0	.	.	43	45	CGC	246	248	CGC	80;81;79	C;G;C	80;81;79	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1138	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1146	53.3	1	SNP	p	S33R	0	.	.	97	99	AGC	300	302	AGC	61;59;60	A;G;C	60;59;60	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1138	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1146	53.3	1	SNP	p	G131D	0	.	.	391	393	GGC	594	596	GGC	79;75;75	G;G;C	77;74;68	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1138	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1146	53.3	1	SNP	p	R203C	0	.	.	607	609	CGT	810	812	CGT	81;83;82	C;G,A;T	81;82,1;82	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1138	nfsA	723	723	99.03	nfsA.l15.c4.ctg.1	1146	53.3	1	SNP	p	R203L	0	.	.	607	609	CGT	810	812	CGT	81;83;82	C;G,A;T	81;82,1;82	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	2658	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1483	96.0	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1135	1137	GAG	106;106;103	G;A;G	106;106;101	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	2658	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1483	96.0	1	SNP	p	G141D	0	.	.	421	423	GGT	622	624	GGT	124;127;125	G;G;T	124;127;125	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	2658	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1483	96.0	1	SNP	p	G141E	0	.	.	421	423	GGT	622	624	GGT	124;127;125	G;G;T	124;127;125	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	2658	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1483	96.0	1	SNP	p	R154A	0	.	.	460	462	CGT	661	663	CGT	123;129;129	C;G;T	123;129;128	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	2658	ompF	1089	1089	99.91	ompF.l15.c30.ctg.1	1483	96.0	1	SNP	p	R154D	0	.	.	460	462	CGT	661	663	CGT	123;129;129	C;G;T	123;129;128	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	5294	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2737	103.8	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1820	1822	GTG	123;123;121	G;T;G	123;123;121	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	5294	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2737	103.8	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1847	1849	TCG	106;105;107	T;C;G	91;95;99	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	5294	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2737	103.8	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2462	2464	AAC	83;81;80	A;A;C	81;81;79	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	5294	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2737	103.8	1	SNP	p	A85T	0	.	.	253	255	GCG	476	478	GCG	102;101;105	G;C;G	100;97;102	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	5294	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2737	103.8	1	SNP	p	D111H	0	.	.	331	333	GAT	554	556	GAT	99;97;99	G;A;T	98;95;98	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	5294	parC_2	2259	2259	99.2	parC_2.l15.c30.ctg.1	2737	103.8	1	SNP	p	S129P	0	.	.	385	387	TCC	608	610	TCC	106;109;107	T;C;C	102;107;106	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	3166	parE_1	1893	1893	97.52	parE_1.l15.c17.ctg.1	2370	71.8	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1644	1646	AAC	98;98;98	A,G;A;C	95,2;98;98	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	3166	parE_1	1893	1893	97.52	parE_1.l15.c17.ctg.1	2370	71.8	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1653	1655	GAT	112;114;114	G;A,C;T	112;111,2;112	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	2806	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1823	82.5	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	820	822	CAG	94;93;97	C;A,C;G	94;92,1;96	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	2806	patA	1380	1380	99.78	patA.l15.c4.ctg.1	1823	82.5	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1294	1296	GAT	104;107;106	G;A;T	104;106;105	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	9030	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4535	107.1	1	SNP	p	V146F	0	.	.	436	438	GTT	684	686	GTT	98;97;95	G;T;T	98;97;94	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	9030	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4535	107.1	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1785	1787	CAG	85;84;86	C;A;G	85;84;86	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	9030	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4535	107.1	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1785	1787	CAG	85;84;86	C;A;G	85;84;86	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	9030	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4535	107.1	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1824	1826	CAC	100;101;104	C;A;C	99;101;104	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	9030	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4535	107.1	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1833	1835	CGT	106;108;107	C;G;T	105;108;107	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	9030	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4535	107.1	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1833	1835	CGT	106;108;107	C;G;T	105;108;107	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	9030	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4535	107.1	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1839	1841	TCC	101;101;97	T;C;C	101;101;97	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	9030	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4535	107.1	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1845	1847	CTC	90;88;88	C;T;C	90;87;87	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	9030	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4535	107.1	1	SNP	p	T563P	0	.	.	1687	1689	ACC	1935	1937	ACC	102;104;104	A;C;C	102;104;104	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	9030	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4535	107.1	1	SNP	p	P564L	0	.	.	1690	1692	CCT	1938	1940	CCT	104;107;109	C;C;T	104;107;108	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	9030	rpoB	4029	4029	99.03	rpoB.l6.c4.ctg.1	4535	107.1	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2307	2309	CGT	181;181;177	C;G;T	181;180;175	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	1001	99.8	rrsB+.l15.c17.ctg.1	1148	635.6	0	.	n	.	0	A226G	SNP	226	226	A	373	373	G	766	G	764	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	1001	99.8	rrsB+.l15.c17.ctg.1	1148	635.6	0	.	n	.	0	C719T	SNP	719	719	C	866	866	T	601	T,C	270,329	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	1001	99.8	rrsB+.l15.c17.ctg.1	1148	635.6	1	SNP	n	A794G	0	.	.	794	794	A	941	941	A	691	A	684	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	1001	99.8	rrsB+.l15.c17.ctg.1	1148	635.6	1	SNP	n	A794T	0	.	.	794	794	A	941	941	A	691	A	684	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	1001	99.8	rrsB+.l15.c17.ctg.1	1148	635.6	1	SNP	n	G926C	0	.	.	926	926	G	1073	1073	G	709	G	705	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	1001	99.8	rrsB+.l15.c17.ctg.1	1148	635.6	1	SNP	n	G926A	0	.	.	926	926	G	1073	1073	G	709	G	705	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	1001	99.8	rrsB+.l15.c17.ctg.1	1148	635.6	1	SNP	n	G926T	0	.	.	926	926	G	1073	1073	G	709	G	705	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	1001	99.8	rrsB+.l15.c17.ctg.1	1148	635.6	0	HET	.	.	.	A79G,C	.	79	79	A	226	226	A	634	A,G,C	478,149,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	1001	99.8	rrsB+.l15.c17.ctg.1	1148	635.6	0	HET	.	.	.	T273A	.	273	273	T	420	420	T	682	T,A	516,158	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	1001	99.8	rrsB+.l15.c17.ctg.1	1148	635.6	0	HET	.	.	.	C183T	.	183	183	C	330	330	C	687	C,T	436,243	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	1001	99.8	rrsB+.l15.c17.ctg.1	1148	635.6	0	HET	.	.	.	T90C	.	90	90	T	237	237	T	626	T,C	474,146	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	1001	99.8	rrsB+.l15.c17.ctg.1	1148	635.6	0	HET	.	.	.	A250T	.	250	250	A	397	397	A	694	A,T	517,173	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	1001	99.8	rrsB+.l15.c17.ctg.1	1148	635.6	0	HET	.	.	.	G474A	.	474	474	G	621	621	G	728	G,A	538,190	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	1001	99.8	rrsB+.l15.c17.ctg.1	1148	635.6	0	HET	.	.	.	A253T	.	253	253	A	400	400	A	709	A,T	536,170	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	1001	99.8	rrsB+.l15.c17.ctg.1	1148	635.6	0	HET	.	.	.	C194T	.	194	194	C	341	341	C	728	C,T	562,161	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	518	100.0	rrsB+.l15.c17.ctg.2	710	612.0	1	SNP	n	A1519C	0	.	.	1519	1519	A	495	495	A	596	A	588	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	518	100.0	rrsB+.l15.c17.ctg.2	710	612.0	1	SNP	n	A1519T	0	.	.	1519	1519	A	495	495	A	596	A	588	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	518	100.0	rrsB+.l15.c17.ctg.2	710	612.0	1	SNP	n	A1519G	0	.	.	1519	1519	A	495	495	A	596	A	588	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	518	100.0	rrsB+.l15.c17.ctg.2	710	612.0	0	HET	.	.	.	C1038T,G	.	1038	1038	C	14	14	C	394	C,T,G	122,83,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	115	94.83	rrsB+.l15.c17.ctg.3	115	106.2	0	.	n	.	0	G1002A	SNP	1002	1002	G	46	46	A	185	A	185	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	115	94.83	rrsB+.l15.c17.ctg.3	115	106.2	0	.	n	.	0	G1006C	SNP	1006	1006	G	50	50	C	187	C	187	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	115	94.83	rrsB+.l15.c17.ctg.3	115	106.2	0	.	n	.	0	T1010C	SNP	1010	1010	T	54	54	C	189	C	187	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	115	94.83	rrsB+.l15.c17.ctg.3	115	106.2	0	.	n	.	0	A1019.	DEL	1019	1019	A	62	62	G	189	G	189	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	115	94.83	rrsB+.l15.c17.ctg.3	115	106.2	0	.	n	.	0	.1023G	INS	1023	1023	T	67	67	G	177	G	176	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	115	94.83	rrsB+.l15.c17.ctg.3	115	106.2	0	HET	.	.	.	C1038T	.	1038	1038	C	82	82	C	108	C,T	0,106	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	22782	rrsB+	1542	127	100.0	rrsB+.l15.c17.ctg.4	127	112.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	1094	soxR	465	465	100.0	soxR.l15.c4.ctg.1	861	68.2	1	SNP	p	R20H	0	.	.	58	60	CGC	254	256	CGC	100;100;99	C;G,C;C	99;99,1;99	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	1094	soxR	465	465	100.0	soxR.l15.c4.ctg.1	861	68.2	1	SNP	p	G121D	0	.	.	361	363	GGT	557	559	GGT	95;93;97	G;G;T	95;93;96	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	754	soxS_1	324	324	99.69	soxS_1.l15.c17.ctg.1	787	51.4	1	SNP	p	A12S	0	.	.	34	36	GCA	241	243	GCA	101;101;99	G;C;A	101;101;99	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	3318	tolC	1488	1488	98.72	tolC.l6.c30.ctg.1	1944	91.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.;tolC
